跳至主要内容
临床试验/NCT02646631
NCT02646631已完成不适用

Behavioral and Educational Tools to Improve Epilepsy Care

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
Percent adherence to anti-epileptic drug schedule (pill counts)

研究概览

简要总结

The long-term goal of this research is to improve seizure control among patients with epilepsy, which has the potential to improve quality of life for thousands of people living with epilepsy and reduce health care utilization, social and economic costs, and epilepsy-related mortalities. Participants who are suffering from epilepsy will be randomized to receive usual care (UC), a smartphone-based self-management intervention called Management of Risks in Epilepsy (MORE), or MORE + telephone-based motivational interviewing (MI). Participants will be followed for 3 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • English- or Spanish-speaking
  • Partial (focal) or generalized epilepsy (as confirmed with epileptiform activity on an electroencephalogram)
  • Poor medication adherence
  • Willing and able to use a smartphone (provided by the study) to manage disease.

排除标准

  • Known or suspected psychogenic nonepileptic seizures as sole seizure type
  • Active psychotic disorder

结局指标

主要结局

Percent adherence to anti-epileptic drug schedule (pill counts)

时间窗: 3 months

次要结局

  • Quality of life as measured by the PROMIS-10 questionnaire score(3 months)
  • Seizure frequency(3 months)
  • Quality of life as measured by the Quality of Life in Epilepsy questionnaire score(3 months)
  • Number of patients who complete the study(3 months)
  • Adherence to anti-epileptic drug schedule (self-reported) as measured by the Morisky Medication Adherence Scale(3 months)
  • Percentage of MI sessions completed(3 months)
  • Percentage of diary entries completed(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验